Music Therapy in Sickle Cell Transition Study

University Hospitals (UH)

Status: Completed

Conditions: Sickle Cell Disease

Treatments: Behavioral: Music Therapy

Study type: Interventional

Funder types: Other

Identifiers

NCT02466555

03-15-30

Details and patient eligibility

About

The purpose of this study is to investigate the effects of the BEATS Music Therapy Program on the self-efficacy, trust, knowledge, and adherence of young adult patients with sickle cell disease during transition.

Primary Hypotheses:

Compared to baseline, young adult patients with sickle cell disease who receive the music therapy interventions will report:

1. Higher sickle cell self-efficacy as measured by the Sickle Cell Self Efficacy Scale (SCSES),
2. Higher trust in health care providers as measured by the Wake Forest Trust in the Medical Profession Scale, and
3. Higher sickle cell disease knowledge as measured by the Seidman Sickle Cell Knowledge Quiz.

Secondary Hypotheses

1. Compared to the one year prior to the study period, young adults with sickle cell disease who receive the music therapy interventions will have a higher rate of adherence to clinic appointments during the one-year study period.

Additional Questions

1. Do music therapy interventions influence attendance to scheduled blood transfusions?
2. Do music therapy interventions influence the rate of hospital utilization as measured by Emergency Department visits, Acute Care Clinic visits, and admissions during the study period compared to the previous year?
3. Do music therapy interventions influence adherence to hydroxyurea therapy for patients receiving hydroxyurea as measured by change in mean corpuscular volume (MCV) during the study period?
4. Do music therapy interventions influence adherence to iron chelation therapy for patients receiving iron chelation therapy as measured by ferritin count during the study period?

Enrollment: 30 patients

Sex: All

Ages: 18 to 23 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subject is between 18 and 23 years of age
• Subject is diagnosed with sickle cell disease
• Subject is able to speak and understand English
• Subject is currently scheduled for quarterly appointments in the Bridge Clinic

Exclusion criteria

• Subject has significant hearing impairment that has not been corrected
• Subject has significant visual impairment that has not been corrected

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

30 participants in 1 patient group

Music Therapy Group

Experimental group

Description:

Music therapy is the clinical and evidence-based use of music interventions to accomplish individualized goals within a therapeutic relationship by a credentialed professional who has completed an approved music therapy program. Music therapy is an established health profession in which music is used within a therapeutic relationship to address physical, emotional, cognitive, and social needs of individuals (American Music Therapy Association \[AMTA\], 2013, para 1 and 2).

Treatment:

Behavioral: Music Therapy